Serial 79052271
Live / Registered — Registered — Section 71 accepted (as of 02 Apr 2019)
What this means for you
Registered since 16 Sept 2008. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79052271
- Registration number
- 3502080
- Mark type
- Design / logo
- Filed
- 25 Jul 2007
- Published for opposition
- 01 Jul 2008
- Registered
- 16 Sept 2008
- Attorney of record
- Max Vern
Goods and services
- Class 001 — Chemicals: Biochemical, namely, monoclonal antibodies for in vivo or in vitro scientific research and in vivo or in vitro development in the field of cancer [, AIDS, acquired immune deficiency syndrome, ] and other infectious diseases, immune and autoimmune diseases, inflammatory diseases [ and cardiovascular diseases ]
- Class 005 — Pharmaceuticals: Pharmaceutical preparations based on human monoclonal antibodies for use in the treatment of cancer [, AIDS, acquired immune deficiency syndrome, ] and other infectious diseases, immune and autoimmune diseases, inflammatory diseases [ and cardiovascular diseases ]
- Class 042 — Scientific and technological services: Medical scientific research, namely, biological research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for use in the treatment of cancer, AIDS, acquired immune deficiency syndrome, and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis, patent exploitation, licensing of intellectual property in the field of medicine; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies
Owner
- Genmab A/S, DK
- Genmab A/S, DK-1253 København K, DK
- Genmab A/S, DK-1253 København K, DK
Prosecution history
- 24 Mar 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 05 Feb 2025 — INTERNATIONAL REGISTRATION RENEWED
- 05 Jun 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 05 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jun 2024 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 05 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Jun 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Jun 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Sept 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 21 Feb 2020 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 03 Jan 2020 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 03 Jan 2020 — INVALIDATION PROCESSED
- 02 Dec 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 02 Apr 2019 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED